University Cancer Research Fund
The University Cancer Research Fund (UCRF) is a nation-leading investment to stimulate cancer research and reduce North Carolina’s leading cause of death. The Fund builds upon the exceptional research base at UNC Lineberger Comprehensive Cancer Center, the state’s only public, NCI-designated comprehensive cancer center.
UCRF’s Goal
To create a nation-leading cancer research effort and to reduce North Carolina’s cancer burden. UCRF is accomplishing these goals through:
- Discovery to better understand the causes and course of cancer.
- Innovation to create new and better ways to prevent, diagnose and treat cancer.
- Delivery of improved cancer care, screening and prevention across the state.
Latest News
-
Investigating approaches to make lung cancer screening more effective
To better understand the burdens of false-positive lung cancer screenings and ways to mitigate them, the NCI awarded UNC Lineberger researchers a $3.2 million grant to identify the potential harms of false-positive results at the patient, clinician, and facility levels.
-
“Data for everyone”: A new cancer dashboard launches at UNC Lineberger Comprehensive Cancer Center
UNC Lineberger has launched a resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.
-
Community Advisory Board engages NC communities in the fight against cancer
UNC Lineberger’s Community Advisory Board works to make sure cancer research reflects community needs across the state, and to raise public awareness of cancer’s signs and symptoms.
-
Building tools to help doctors better track patient symptoms, improve outcomes
Digital reporting technologies created by UNC Lineberger researchers are now being used in North Carolina and across the country to improve care and outcomes for cancer patients.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.